Evidence map›Paper›PMID 26220445›Full record

ArticleBMC genomics2015

Quantitative proteomic analysis of formalin-fixed, paraffin-embedded clear cell renal cell carcinoma tissue using stable isotopic dimethylation of primary amines.

J Weißer, Z W Lai, P Bronsert, M Kuehs, V Drendel, S Timme, S Kuesters, C A Jilg, U F Wellner, S Lassmann and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling.Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

J WeißerInstitute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany. JWeisser@cemm.oeaw.ac.at.
Z W LaiInstitute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany. zon.lai@mol-med.uni-freiburg.de.
P BronsertDepartment of Pathology, University Medical Center Freiburg, Freiburg, Germany. peter.bronsert@uniklinik-freiburg.de.
M KuehsDepartment of Pathology, University Medical Center Freiburg, Freiburg, Germany. markus.kuehs@uniklinik-freiburg.de.
V DrendelDepartment of Pathology, University Medical Center Freiburg, Freiburg, Germany. vanessa.drendel@uniklinik-freiburg.de.
S TimmeDepartment of Pathology, University Medical Center Freiburg, Freiburg, Germany. sylvia.timme@uniklinik-freiburg.de.
S KuestersClinic for General and Visceral Surgery, University Medical Center Freiburg, Freiburg, Germany. simon.kuesters@uniklinik-freiburg.de.
C A JilgUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Freiburg, 79106, Germany. cordula.jilg@uniklinik-freiburg.de.
U F WellnerClinic for General and Visceral Surgery, University Medical Center Freiburg, Freiburg, Germany. dr.ulrich.wellner@gmail.com.
S LassmannDepartment of Pathology, University Medical Center Freiburg, Freiburg, Germany. silke.lassmann@uniklinik-freiburg.de.
M WernerDepartment of Pathology, University Medical Center Freiburg, Freiburg, Germany. martin.werner@uniklinik-freiburg.de.
M L BiniossekInstitute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany. martin.biniossek@mol-med.uni-freiburg.de.
O SchillingInstitute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany. oliver.schilling@mol-med.uni-freiburg.de.
University Medical Center Freiburg · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFormalin-fixed, paraffin-embedded (FFPE) tissues represent the most abundant resource of archived human specimens in pathology. Such tissue specimens are emerging as a highly valuable resource for translational proteomic studies. In quantitative proteomic analysis, reductive di-methylation of primary amines using stable isotopic formaldehyde variants is increasingly used due to its robustness and cost-effectiveness.

resultsIn the present study we show for the first time that isotopic amine dimethylation can be used in a straightforward manner for the quantitative proteomic analysis of FFPE specimens without interference from formalin employed in the FFPE process. Isotopic amine dimethylation of FFPE specimens showed equal labeling efficiency as for cryopreserved specimens. For both FFPE and cryopreserved specimens, differential labeling of identical samples yielded highly similar ratio distributions within the expected range for dimethyl labeling. In an initial application, we profiled proteome changes in clear cell renal cell carcinoma (ccRCC) FFPE tissue specimens compared to adjacent non-malignant renal tissue. Our findings highlight increased levels of glyocolytic enzymes, annexins as well as ribosomal and proteasomal proteins.

conclusionOur study establishes isotopic amine dimethylation as a versatile tool for quantitative proteomic analysis of FFPE specimens and underlines proteome alterations in ccRCC.

Indexed as

ProteomicsAminesCarbon IsotopesCarcinoma, Renal CellChromatography, High Pressure LiquidFormaldehydeHumansIsotope LabelingKidney NeoplasmsParaffin EmbeddingProteomeTandem Mass SpectrometryAminesCarbon IsotopesFormaldehydeProteome

Identifiers

PMID26220445
PMCPMC4518706
OpenAlexW1811584487

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.